CervoMed Profit Margin

The latest profit margin for CRVO is -9160.94% as of June 2026. That compares with -1286.43% in the prior-year period — down 612.1% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside CervoMed's historical trend and sector peers before judging valuation or financial health.

Over the past year, CRVO's profit margin moved from -1286.43% to -9160.94% — a 612.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CervoMed's valuation or profitability profile.

Against Healthcare companies, CRVO currently prints -9160.94% for profit margin, while the sector average sits near 14.34%. That is roughly 63962.5% below the sector mean. Large gaps often invite a closer look at CervoMed's growth, margins, and balance sheet.

Profit Margin shows how effectively CervoMed converts resources into returns. At -9160.94%, CRVO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1286.43% in the prior-year period — down 612.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CRVO's profit margin (-9160.94%), review year-over-year change from -1286.43%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.